⌘K

Login Start Free

Home/Filings/4/0000950170-24-081259

4//SEC Filing

Clark Eliana 4

Accession 0000950170-24-081259

CIK 0001652130other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 1:15 PM ET

Size

4.7 KB

Accession

0000950170-24-081259

Insider Transaction Report

Form 4

Period: 2024-07-01

Intellia Therapeutics, Inc.NTLA

EVP, Chief Technical Officer

Transactions

Sale
Common Stock
2024-07-01$22.93/sh−405$9,287→ 71,470 total

Footnotes (1)

[F1]Sale of 405 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 28, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1

filerCIK 0001914448

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 1:15 PM ET
Size: 4.7 KB

View on SEC.gov